“Why take it if you don’t have anything?” breast cancer risk perceptions and prevention choices at a public hospital
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
BACKGROUND: Despite advances in breast cancer risk assessment and risk reduction technologies, little is still known about how high-risk women make sense of their risk and assess prevention options, particularly among minority and low-income women. Qualitative methods explore the complex meanings and logics of risk and prevention that quantitative approaches overlook.
OBJECTIVE: This study examined how women attending a high risk breast cancer clinic at a public hospital conceptualize their breast cancer risk and think about the prevention options available to them.
METHODS: Semi-structured interviews were used to gather data from 33 high-risk women (75% African American) between May and August 2004. Interview transcripts were analyzed for recurrent themes and patterns.
RESULTS: Despite general awareness of their objective risk status, many women in this study reported they did not feel “high risk” because they lacked signs and symptoms of cancer. Risk was described as an experienced acute problem rather than a statistical possibility. Women also frequently stated that thinking about cancer might cause it to happen and so it is better not to “dwell on it.” While screening was welcomed, women were generally skeptical about primary prevention. In particular, preventive therapies were perceived to cause problems and were only acceptable as treatment options for a disease.
CONCLUSIONS: The body of ideas about risk and prevention expressed by this population differ from the medical model. These findings have implications for risk perception research as well as for the efficacy of risk communication and prevention counseling in clinical contexts.
- Armstrong K. Leading the way in breast cancer screening and prevention. J Gen Intern Med. 2004;10:390–1. CrossRef
- Sugg Skinner C, Rawl SM, Moser BK, et al. Impact of the cancer risk intake system on patient-clinician discussions of tamoxifen, genetic counseling, and colonoscopy. J Gen Intern Med. 2005;20:360–5. CrossRef
- Sakorafas GH, Krespis E, Pavlakis G. Risk estimation for breast cancer development; a clinical perspective. Surg Oncol. 2002;10:183–92. CrossRef
- King MC, Marks JH, Mandell JB. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science. 2003;302:643–6. CrossRef
- Robson ME. Clinical considerations in the management of individuals at risk for hereditary breast and ovarian cancer. Cancer Control. 2002;9:457–65.
- U.S. Preventive Services Task Force. Chemoprevention of breast cancer: recommendations and rationale. Ann Intern Med. 2002;137:56–58.
- Schrag D, Kuntz KM, Garber JE, Weeks JC. Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations. JAMA. 2000;283:617–24. CrossRef
- Grann VR, Jacobson JS, Thomason D, Hershman D, Heitjan DF, Neugut AI. Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1/2 mutations: an updated decision analysis. J Clin Oncol. 2002;20:2520–9. CrossRef
- Haas JS, Kaplan CP, Gregorich SE, Pérez-Stable EJ, des Jarlais G. Do physicians tailor their recommendations for breast cancer risk reduction based on patient’s risk? J Gen Intern Med. 2004;19:302–9. CrossRef
- Hopwood P. Breast cancer risk perception: what do we know and understand? Breast Cancer Res. 2000;2:387–91. CrossRef
- Lerman C, Hughes C, Croyle RT, et al. Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing. Prev Med. 2000;31:75–80. CrossRef
- Hughes C, Lerman C, Lustbader E. Ethnic differences in risk perception among women at increased risk for breast cancer. Breast Cancer Res Treat. 1996;40:25–35. CrossRef
- Donovan KA, Tucker DC. Knowledge about genetic risk for breast cancer and perceptions of genetic testing in a sociodemographically diverse sample. J Behav Med. 2000;23:15–36. CrossRef
- Eisinger F, Julian-Reynier C, Sobol H, Stoppa-Lyonnet D, Lasset C, Nogues C. Acceptability of prophylactic mastectomy in cancer-prone women. JAMA. 2000;283:202–3. CrossRef
- Ang P, Yong K-Y, Tan K-S. Low acceptance of prophylactic surgery and chemoprevention even in individuals at increased risk of cancer in Singapore. ASCO Annual Meeting 2003. Proc Am Soc Clin Oncol. 2003;22:540 (abstr 2174).
- Meiser B, Eisenbruch M, Barlow-Stewart K, Tucker K, Steel Z, Goldstein D. Cultural aspects of cancer genetics: setting a research agenda. J Med Genet. 2001;38:425–9. CrossRef
- Sanders T, Campbell R, Sharp D, Donovan J. Risk constructions among people who have a first-degree relative with cancer. Health Risk Soc. 2003;5:53–69. CrossRef
- Bouchard L, Blancquaert I, Eisinger F, et al. Prevention and genetic testing for breast cancer: variations in medical decisions. Soc Sci Med. 2004;58:1085–96. CrossRef
- Julian-Reynier C, Eisinger F, Evans G, Foulkes W, Sobol H. Variation in prophylactic surgery decisions. Lancet. 2000;356:1687. CrossRef
- Hughes C, Fasaye GA, LaSalle VH, Finch C. Sociocultural influences on participation in genetic risk assessment and testing among African American women. Patient Educ Couns. 2003;51:107–14. CrossRef
- Hallowell N, Jacobs I, Richards M, Mackay J, Gore M. Surveillance or surgery? A description of the factors that influence high risk premenopausal women’s decisions about prophylactic oophorectomy. J Med Genet. 2001;38:683–91. CrossRef
- Eisinger F, Geller G, Burke W, Holtzman NA. Cultural basis for differences between US and French clinical recommendations for women at increased risk of breast and ovarian cancer. Lancet. 1999;353:919–20. CrossRef
- Chalmers K, Thomson K. Coming to terms with the risk of breast cancer: perceptions of women with primary relatives with breast cancer. Qual Health Res. 1996;6:256–82. CrossRef
- Lannin DR, Mathews HF, Mitchell J, Swanson MS. Impacting cultural attitudes in African-American women to decrease breast cancer mortality. Am J Surg. 2002;184:418–23. CrossRef
- Kerner JF. Breast cancer prevention and control among the medically underserved. Breast Cancer Res Treat. 1996;40:1–9. CrossRef
- Guidry JJ, Matthews-Juarez P, Copeland VA. Barriers to breast cancer control for African-American women: the interdependence of culture and psychosocial issues. Cancer. 2003;97:318–23. CrossRef
- Marcus AC. New directions for risk communication research: a discussion with additional suggestions. J Natl Cancer Inst Monogr. 1999;25:35–42.
- Stefanek M, Hartmann L, Nelson W. Risk-reduction mastectomy: clinical issues and research needs. J Natl Cancer Inst. 2001;93:1297–306. CrossRef
- Crabtree BF, Miller WL. Doing Qualitative Research in Primary Care: Multiple Strategies. Thousand Oaks, CA: Sage Publications; 1992.
- Willms DG, Best JA, Taylor DW, et al. A systematic-approach for using qualitative methods in primary prevention research. Med Anthropol Quart. 1990;4:391–409. CrossRef
- Rajaram SS, Rashidi A. Minority women and breast cancer screening: the role of cultural explanatory models. Prev Med. 1998;27:757–64. CrossRef
- Gregg J, Curry RH. Explanatory models for cancer among African-American women at two Atlanta neighborhood health centers: the implications for a cancer screening program. Soc Sci Med. 1994;39:519–26. CrossRef
- Dein S. Explanatory models of and attitudes towards cancer in different cultures. Lancet Oncol. 2004;5:119–24. CrossRef
- Davison C, Smith GD, Frankl S. Lay epidemiology and the prevention paradox-the implications of coronary candidacy for health-education. Sociology Health Illness. 1991;13:1–19. CrossRef
- Strauss A, Corbin J Grounded theory methodology—an overview. In: Denzin NK, Lincoln YS, eds. Handbook of Qualitative Research. Thousand Oaks, CA: Sage Publications; 1994:273–85.
- Kenen R, Arden-Jones A, Eeles RA. Living with chronic risk: healthy women with a family history of breast/ovarian cancer. Health Risk Soc. 2003;5:315–31. CrossRef
- Martino S, Costantino J, McNabb M, et al. The role of selective estrogen receptor modulators in the prevention of breast cancer: comparison of the clinical trials. Oncologist. 2004;9:116–25. CrossRef
- Skolbekken JA. The risk epidemic in medical journals. Soc Sci Med. 1995;40:291–305. CrossRef
- Jacobs LA. An analysis of the concept of risk. Cancer Nurs. 2000;23:12–9. CrossRef
- Mathews HF, Lannin DR, Mitchell JP. Coming to terms with advanced breast cancer: black women’s narratives from eastern North Carolina. Soc Sci Med. 1994;38:789–800. CrossRef
- Hoffman-Goetz L, Mills SL. Cultural barriers to cancer screening among African American women: a critical review of the qualitative literature. Womens Health. 1997;3:183–201.
- Tessaro I, Eng E, Smith J. Breast cancer screening in older African-American women: qualitative research findings. Am J Health Promot. 1994;8:286–92.
- Matthews AK, Cummings S, Thompson S, List M, Olopade OI. Genetic testing of African Americans for susceptibility to inherited cancers: use of focus groups to determine factors contributing to participation. J Psych Oncol. 2000;18:1–19. CrossRef
- Davison C, Frankel S, Smith GD. The limits of lifestyle: re-assessing “fatalism” in the popular culture of illness prevention. Soc Sci Med. 1992;34:675–85. CrossRef
- Sturges JE, Hanrahan KJ. Comparing telephone and face-to-face qualitative interviewing: a research note. Qualitative Research. 2004;4:107–18. CrossRef
- Burt J, Caelli K, Moore K, Anderson M. Radical prostatectomy: men’s experiences and postoperative needs. J Clin Nurs. 2005;14:883–90. CrossRef
- Tomaino-Brunner C, Freda MC, Runowicz CD. “I hope I don’t have cancer”: colposcopy and minority women. Oncol Nurs Forum. 1996;23:39–44.
- Baty BJ, Kinney AY, Ellis SM. Developing culturally sensitive cancer genetics communication aids for African Americans. Am J Med Genet. 2003;118A:146–55. CrossRef
- “Why take it if you don’t have anything?” breast cancer risk perceptions and prevention choices at a public hospital
Journal of General Internal Medicine
Volume 21, Issue 7 , pp 779-785
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- risk perception
- breast cancer
- underserved populations
- Industry Sectors
- Author Affiliations
- 1. Pritzker Medical School and the History of Culture, University of Chicago, Chicago, IL, USA
- 2. Breast & Cervical Cancer Screening Program, Cook County Hospital, Chicago, IL, USA
- 3. Rush Medical College, Chicago, IL, USA
- 4. Center for Clinical Cancer Genetics, University of Chicago, IL, USA
- 5. Hematology/Oncology Section, University of Chicago, Chicago, IL, USA
- 6. Department of Health Studies, University of Chicago, 5841 Maryland Ave., MC 2007, 60637, Chicago, IL